| Omalizumab in children with uncontrolled allergic asthma: review of clinical trial and real-world experience BE Chipps, B Lanier, H Milgrom, A Deschildre, G Hedlin, SJ Szefler, ... Journal of Allergy and Clinical Immunology 139 (5), 1431-1444, 2017 | 178 | 2017 |
| Addressing the childhood asthma crisis in Harlem: the Harlem Children’s Zone Asthma Initiative SW Nicholas, B Jean-Louis, B Ortiz, M Northridge, K Shoemaker, ... American Journal of Public Health 95 (2), 245-249, 2005 | 148 | 2005 |
| Benefits and harms of omalizumab treatment in adolescent and adult patients with chronic idiopathic (spontaneous) urticaria: a meta-analysis of “real-world” evidence MD Tharp, JA Bernstein, A Kavati, B Ortiz, K MacDonald, K Denhaerynck, ... JAMA dermatology 155 (1), 29-38, 2019 | 139 | 2019 |
| Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis ME Wechsler, AD Klion, P Paggiaro, P Nair, D Staumont-Salle, A Radwan, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (10), 2695-2709, 2022 | 130 | 2022 |
| The national cost of asthma among school-aged children in the United States PW Sullivan, V Ghushchyan, P Navaratnam, HS Friedman, A Kavati, ... Annals of allergy, asthma & immunology 119 (3), 246-252. e1, 2017 | 122 | 2017 |
| Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’evidence JA Bernstein, A Kavati, MD Tharp, B Ortiz, K MacDonald, K Denhaerynck, ... Expert opinion on biological therapy 18 (4), 425-448, 2018 | 96 | 2018 |
| Short-and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018 KM MacDonald, A Kavati, B Ortiz, A Alhossan, CS Lee, I Abraham Expert review of clinical immunology 15 (5), 553-569, 2019 | 88 | 2019 |
| More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II BE Chipps, T Haselkorn, B Paknis, B Ortiz, ER Bleecker, F Kianifard, ... Journal of Allergy and Clinical Immunology 141 (5), 1590-1597. e9, 2018 | 82 | 2018 |
| Efficacy and safety of omalizumab in children and adolescents with moderate-to-severe asthma: a systematic literature review J Corren, A Kavati, B Ortiz, JA Colby, K Ruiz, BA Maiese, SM Cadarette, ... Allergy and Asthma Proceedings 38 (4), 250-263, 2017 | 78 | 2017 |
| Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status S Fujieda, S Matsune, S Takeno, N Ohta, M Asako, C Bachert, T Inoue, ... Allergy 77 (1), 186-196, 2022 | 75 | 2022 |
| The national burden of poorly controlled asthma, school absence and parental work loss among school-aged children in the United States PW Sullivan, V Ghushchyan, P Navaratnam, HS Friedman, A Kavati, ... Journal of Asthma 55 (6), 659-667, 2018 | 75 | 2018 |
| School absence and productivity outcomes associated with childhood asthma in the USA P Sullivan, VG Ghushchyan, P Navaratnam, HS Friedman, A Kavati, ... Journal of Asthma 55 (2), 161-168, 2018 | 68 | 2018 |
| Childhood asthma and extreme values of body mass index: the Harlem Children’s Zone Asthma Initiative HL Kwon, B Ortiz, R Swaner, K Shoemaker, B Jean-Louis, ME Northridge, ... Journal of Urban Health 83, 421-433, 2006 | 67 | 2006 |
| Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or … M Maurer, H Sofen, B Ortiz, F Kianifard, S Gabriel, JA Bernstein Journal of the European Academy of Dermatology and Venereology 31 (6), 1056-1063, 2017 | 65 | 2017 |
| Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps C Hopkins, M Wagenmann, C Bachert, M Desrosiers, JK Han, ... International forum of allergy & rhinology 11 (7), 1087-1101, 2021 | 63 | 2021 |
| Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: results from two … J Mullol, TM Laidlaw, C Bachert, LP Mannent, GW Canonica, JK Han, ... Allergy 77 (4), 1231-1244, 2022 | 62 | 2022 |
| National prevalence of poor asthma control and associated outcomes among school-aged children in the United States PW Sullivan, V Ghushchyan, P Navaratnam, HS Friedman, A Kavati, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (2), 536-544. e1, 2018 | 49 | 2018 |
| Baseline FeNO independently predicts the dupilumab response in patients with moderate-to-severe asthma ID Pavord, Y Deniz, J Corren, TB Casale, JM FitzGerald, K Izuhara, ... The Journal of Allergy and Clinical Immunology: In Practice 11 (4), 1213 …, 2023 | 45 | 2023 |
| Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma WW Busse, M Humbert, T Haselkorn, B Ortiz, BL Trzaskoma, ... Annals of Allergy, Asthma & Immunology 124 (2), 190-196, 2020 | 44 | 2020 |
| Reducing childhood asthma through community-based service delivery--New York City, 2001-2004. SW Nicholas, VE Hutchinson, B Ortiz, S Klihr-Beall, B Jean-Louis, ... MMWR: Morbidity & Mortality Weekly Report 54 (1), 2005 | 44 | 2005 |